SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With reference to the news appeared in Business Standard dated June 08, 2015 captioned ‘Wockhardt dips after the US FDA asks to recall drugs’, Wockhardt has Clarified that they would like to state that the Company had already informed the exchange on 28th April, 2015 and 15th May, 2015 about recall of products. Further, the Company keeps the exchange informed about events, information etc. including price sensitive information in accordance with regulatory requirements. In present case, we do not have any important information / announcement to be shared. In the event that there is any development that requires disclosure under Clause 36 of the Listing Agreement, we will make the same in accordance with the regulatory requirements.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×